MD4581C1 - 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties - Google Patents

2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties

Info

Publication number
MD4581C1
MD4581C1 MDA20170084A MD20170084A MD4581C1 MD 4581 C1 MD4581 C1 MD 4581C1 MD A20170084 A MDA20170084 A MD A20170084A MD 20170084 A MD20170084 A MD 20170084A MD 4581 C1 MD4581 C1 MD 4581C1
Authority
MD
Moldova
Prior art keywords
myeloid leukemia
ylcarbamothioyl
hydrazino
prop
methyl
Prior art date
Application number
MDA20170084A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD4581B1 (en
Inventor
Аурелиан ГУЛЯ
Василий ГРАУР
Виктор ЦАПКОВ
Original Assignee
Государственный Университет Молд0
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Университет Молд0 filed Critical Государственный Университет Молд0
Priority to MDA20170084A priority Critical patent/MD4581C1/en
Publication of MD4581B1 publication Critical patent/MD4581B1/en
Publication of MD4581C1 publication Critical patent/MD4581C1/en

Links

Landscapes

  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to chemistry and medicine, in particular to a biologically active organic compound of the thiosemicarbazide class and can be used for preventing and treating human myeloid leukemia.According to the invention, claimed is 2-{[(prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound of formula:which has human myeloid leukemia HL-60 cell proliferation inhibitor properties.
MDA20170084A 2017-10-06 2017-10-06 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties MD4581C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20170084A MD4581C1 (en) 2017-10-06 2017-10-06 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20170084A MD4581C1 (en) 2017-10-06 2017-10-06 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties

Publications (2)

Publication Number Publication Date
MD4581B1 MD4581B1 (en) 2018-07-31
MD4581C1 true MD4581C1 (en) 2019-02-28

Family

ID=62974913

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20170084A MD4581C1 (en) 2017-10-06 2017-10-06 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties

Country Status (1)

Country Link
MD (1) MD4581C1 (en)

Also Published As

Publication number Publication date
MD4581B1 (en) 2018-07-31

Similar Documents

Publication Publication Date Title
PH12017502363A1 (en) Brk inhibitory compound
MX2020009347A (en) Picolinamides as fungicides.
MX2018006287A (en) Triazole acc inhibitors and uses thereof.
PH12017502407A1 (en) Fused pyrimidine compound or salt thereof
MX2018006286A (en) Pyrazole acc inhibitors and uses thereof.
MX2017009571A (en) Heterocyclic itk inhibitors for treating inflammation and cancer.
MY196330A (en) Diacylglycerol Acyltransferase 2 Inhibitors
MY196749A (en) Eif4a-inhibiting compounds and methods related thereto
PH12016500225A1 (en) Novel quinoline-substituted compound
SG11201901061QA (en) Heterocyclic compound
AU2015374459A8 (en) Picolinamide compounds with fungicidal activity
MX2016015743A (en) Cyclopropylamine compounds as histone demethylase inhibitors.
PH12017500416A1 (en) Compounds and compositions as raf kinase inhibitors
PH12016502130B1 (en) Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect
MX2016013636A (en) Novel nitrification inhibitors.
MX2020004374A (en) Pharmaceutical composition for prevention or treatment of acute myeloid leukemia or metastatic breast cancer.
MD4215C1 (en) Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide
MX2020011002A (en) Combination comprising hdac inhibitor, lag-3 inhibitor and a pd-1 inhibitor or pd-l1 inhibitor for cancer treatment.
MD4581B1 (en) 2-{[(Prop-2-en-1-ylcarbamothioyl)hydrazino]methyl} pyridinium nitrate compound having human myeloid leukemia HL-60 cell proliferation inhibitor properties
MD4407B1 (en) Inhibitor of human myeloid leukemia HL-60 cells based on bis[N-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamide]nickel(II) chloride hydrate
MD4402C1 (en) Methyl-N'-[(2-hydroxynaphthalene-1-il)methylidene]-N-prop-2-en-1-ylhydrazonothioate, exhibiting antifungal activity against Candida albicans
MD4613B1 (en) Ethyl-4-{2-[(pyridin-2-ylmethylidene)hydrazinocarbothioyl]amino benzoate monohydrate exhibiting properties of human myeloid leukemia HL-60 cell proliferation inhibitor
MD4349B1 (en) N-(3-methoxyphenyl)-2-(pyridine-2-ylmethylene)-hydrazinecarbothioamide compound - inhibitor of human melanoma MeW-164 cell proliferation
PH12015502637A1 (en) Benzothiophene compound
MD4614C1 (en) Dichloro-[N-(3-methoxyphenyl)-2-(pyridine-2-ylmethylene)-hydrazinecarbothioamide]zinc and dichloro-[N-(4-methoxyphenyl)-2-(pyridine-2-ylmethylene)-hydrazinecarbothioamide]zinc as human myeloid leukemia HL-60 cell proliferation inhibitors

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees